Types

Xi in the US

Xi in the US

There’s a glaring absence on the Xi-Obama agenda this week: nuclear weapons.

Next Generation of Middle East Experts in Prague

The one-of-a-kind network of arms control experts reviews past projects and looks forward to the future.

Training Course for Professionals in Chemical, Biological Weapons

CNS Deepens Background of USG Personnel in Chemical, Biological Weapons

CNS offered US government a one-week course on key issues relating to chemical and biological weapons.

nuclear 101

“Nuclear 101”: New Tutorial from CNS & NTI

A new tutorial uses interactive tools to help researchers understand why nuclear materials are unique and how they can be used to generate power—and peril.

NATO and the Baltics

NATO and the Baltics: Regional Views on Deterrence Needs

Some NATO members are pushing for a stronger conventional deterrent against Russia, while acknowledging recent measures are steps in the right direction.

Vanunu Is Israels Edward Snowden

Nuclear Whistle-blower Vanunu Is Israel’s Edward Snowden

Mordechai Vanunu’s first TV interview in Hebrew revealed the intensity of Israeli vindictiveness.

Approaches to Nuclear Cooperation

Approaches to Nuclear Cooperation

The US-South Korea nuclear cooperation agreement has implications for future nonproliferation efforts.

Assessing the Iran Nuclear Deal with Sam Farr

Assessing the Iran Nuclear Deal: A Conversation with Congressman Sam Farr

CNS and MIIS hosted a conversation with Congressman Sam Farr on the Iran nuclear deal on Monday, August 31.

Russian Cruise Missiles and Implications for USNATO

Russian Cruise Missiles and Implications for US/NATO

A new round of Russian cruise missile tests are stirring up yet another source of contention between the United States and Russia.

Can Japan be a bridge-builder for nuclear disarmament Shinzo Abe

Can Japan Become a Bridge-Builder for Nuclear Disarmament?

Japan is uniquely positioned to build bridges in nuclear disarmament and nonproliferation. But will it have the courage to lead?